<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00783120</url>
  </required_header>
  <id_info>
    <org_study_id>RESIS</org_study_id>
    <nct_id>NCT00783120</nct_id>
  </id_info>
  <brief_title>Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Negative Symptoms in Schizophrenia</brief_title>
  <acronym>RESIS</acronym>
  <official_title>Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Negative Symptoms in Schizophrenia - a Multicenter Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Göttingen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Schizophrenia is a major psychotic disorder that presents an enormous burden to the patients
      and their relatives. Despite treatment with second generation antipsychotics, negative
      symptoms and cognitive impairment often persist and determine an unfavourable course
      including reduction in life quality. Prefrontal repetitive transcranial magnetic stimulation
      (rTMS), a promising noninvasive biological technique, applied adjuvant to ongoing
      antipsychotic treatment was demonstrated to be safe and was associated with improvement in
      negative symptoms in the majority of the small placebo-controlled trials.

      The primary objective of the trial is to investigate the efficacy of high-frequency rTMS
      (add-on to antipsychotic therapy) in the treatment of negative symptoms in schizophrenia
      compared to sham stimulation (placebo).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">August 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement in negative symptoms (baseline vs. day 21, PANNS negative sum score)</measure>
    <time_frame>105 Days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>efficacy on cognition, EPS, neuroplasticity (sMRI/MRS), depression, life quality and social function</measure>
    <time_frame>105 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">197</enrollment>
  <condition>Schizophrenia</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10 Hz rTMS of left dorsolateral prefrontal cortex (DLPFC) (15 sessions/3 weeks, 1000 stimuli per session, stimulation intensity 110 % related to the individual resting motor threshold).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>placebo (sham)-rTMS of left DLPFC (15 sessions/3 weeks, 1000 stimuli per session)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Repetitive transcranial magnetic stimulation</intervention_name>
    <description>10 Hz rTMS of left dorsolateral prefrontal cortex (DLPFC) (15 sessions/3 weeks, 1000 stimuli per session, stimulation intensity 110 % related to the individual resting motor threshold); in total 15.000 stimuli.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sham repetitive transcranial magnetic stimulation</intervention_name>
    <description>placebo (sham)-rTMS of left DLPFC (15 sessions/3 weeks, 1000 stimuli per session; in total 15.000 stimuli</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female in-patients and out-patients, 18 - 60 years of age

          -  Diagnostic criteria for schizophrenia according to ICD-10/DSM IV

          -  PANSS negative sum score &gt; 20 points, 1 of items N1 - N7 (range 1 to 7) ≥ 4 (at least
             moderate)

          -  Improvement in PANSS negative sum score less than 10 % in the last 2 weeks prior to
             study entry, stable antipsychotic medication

          -  Informed Consent

        Exclusion Criteria:

          -  Clinically relevant psychiatric comorbidity, verbal IQ &lt; 85

          -  History of epileptic seizures, organic brain disease

          -  Instable medical comorbidity or condition

          -  Previous treatment by rTMS

          -  Factors not compatible with the use of TMS, e.g. cardiac pace makers or other metallic
             implants, pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter G Falkai, Prof MD.</last_name>
    <role>Study Director</role>
    <affiliation>Dept. of Psychiatry and Psychotherapy, University Hospital of the Georg-August-University Göttingen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Psychiatry and Psychotherapy, University of Regensburg</name>
      <address>
        <city>Regensburg</city>
        <state>Bayern</state>
        <zip>93053</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dept. of Psychiatry and Psychotherapy, University Hospital of the Georg-August-University Göttingen</name>
      <address>
        <city>Goettingen</city>
        <state>Niedersachsen</state>
        <zip>37075</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Psychiatry, Heinrich-Heine University Hospital</name>
      <address>
        <city>Duesseldorf</city>
        <state>Nordrhein-Westfalen</state>
        <zip>40629</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 30, 2008</study_first_submitted>
  <study_first_submitted_qc>October 30, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 31, 2008</study_first_posted>
  <last_update_submitted>November 1, 2013</last_update_submitted>
  <last_update_submitted_qc>November 1, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 4, 2013</last_update_posted>
  <responsible_party>
    <name_title>Prof. MD. Peter Falkai</name_title>
    <organization>Dept. of Psychiatry and Psychotherapy</organization>
  </responsible_party>
  <keyword>schizophrenia, negative symptoms, TMS, magnetic stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

